Merck, Schering-Plough Resolve Civil Class-Action Lawsuits Related to VYTORIN, ZETIA | DAIC
Branded Drug Reformulation: The Next Brand vs. Generic Antitrust Battleground
More And More Are “Summarily Ghosted”: Integrilin® Is Now (June 2, 2015) Off-Patent — In The US | New Merck, Reviewed
The Song Remains The Same – Drug/Device Companies Still Should Join PLAC | Drug & Device Law
Untitled
Orange Book Blog: FTC Releases Report on Paragraph IV Litigation Settlements for FY 2010
PDF) Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis
Ethical Considerations for Paragraph IV Matters Before the PTO and Di…
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc., C.A. No. 14-878-LPS-CJB (D. Del. July 20, 2016) | PDF | Generic Drug | Heart Failure
Patent Docs: Teva Pharmaceuticals Int'l GmbH v. Eli Lilly & Co., Eli Lilly & Co. v. Teva Pharmaceuticals Int'l GmbH, and Teva Pharmaceuticals Int'l GmbH v. Eli Lilly & Co. (Fed. Cir.
Schering Corp. v. Geneva Pharmaceuticals, Inc.: Clarification of the Inherent Anticipation Doctrine and Its Implications
Pharma Dynamics (Pty) Ltd v Bayer Pharma AG (formerly Bayer Schering Pharma AG) and another [2014] 4 All SA 302 (SCA)
Obviousness Post-KSR An Unpredictable Season?. 2 2 Cases Post-KSR n n Takeda Chemical Industries v. Alphapharm Pty, Ltd., 492 F.3d 1350, 83 USPQ2d ppt download
Untitled
Schering Corp. v. Geneva Pharms., Inc., 02-1540 _Fed. Cir.…
Untitled
Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: …
Order Admitting To Practice Pro Hac Vice - L-6743-11 Terry Lueckenhoff
Teva Pharmaceuticals - Wikiwand
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ) MILLENNIUM PHARMACEUTICALS, INC., and ) SCHERING CORPORATION,
Order Admitting To Practice Pro Hac Vice - L-3668-10 Hildy Sastre
EX-99.1
Pharmaceutical Patent Two-Step: The Adverse Advent of Amarin v. Hikma Type Litigation* - NYU Journal of Intellectual Property & Entertainment Law
ANDA Approvals | Hatch-Waxman | Robins Kaplan LLP Law Firm
